35 related articles for article (PubMed ID: 35645132)
1. Long-term survival in a patient with advanced lung adenocarcinoma harboring synchronous EGFR exon 18 G719A and BRAF V600E mutations and treated with afatinib: a case report.
Huang Q; Chen C; Hu S; Wu H; Yu D; Zhu X; Xue C; Wu Y; Tang J; Xie R; Ran F
Anticancer Drugs; 2022 Jan; 33(1):e730-e733. PubMed ID: 34387589
[TBL] [Abstract][Full Text] [Related]
2. Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review.
Hong G
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138247
[TBL] [Abstract][Full Text] [Related]
3. Multiple intraventricular metastases from lung adenocarcinoma with EGFR G719X mutation: a case report.
Kong C; Zhou D; Wu N; Bai C
BMC Pulm Med; 2020 May; 20(1):135. PubMed ID: 32393286
[TBL] [Abstract][Full Text] [Related]
4. Durable response to afatinib in advanced lung adenocarcinoma harboring a novel NPTN-NRG1 fusion: a case report.
Nie X; Zhang P; Bie Z; Song C; Zhang M; Ma D; Cui D; Cheng G; Li H; Lei Y; Su X; Wu W; Li L
World J Surg Oncol; 2023 Aug; 21(1):246. PubMed ID: 37587479
[TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal Metastasis, with Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report.
Ota H; Ota T; Narisawa E; Chiba H; Nakayama H; Tsukumo Y; Sakamoto A; Honma N
Intern Med; 2020 Nov; 59(22):2915-2919. PubMed ID: 32727983
[TBL] [Abstract][Full Text] [Related]
6. Case report: A lung squamous cell carcinoma patient with a rare
Zhu ZF; Bao XX; Shi HY; Gu XX
Front Oncol; 2024; 14():1283008. PubMed ID: 38357203
[TBL] [Abstract][Full Text] [Related]
7. Remarkable Response to Immune Checkpoint Inhibitor Monotherapy in an EGFR-Mutant Pulmonary Adenocarcinoma Patient With 0% Expression of PD-L1.
Fujita T; Amano H; Nakamura M; Hirano S; Nakamura S
J Thorac Oncol; 2023 Sep; 18(9):e93-e94. PubMed ID: 37599053
[No Abstract] [Full Text] [Related]
8. Afatinib treatment of severe respiratory failure due to malignant lymphangitis in a dialysis patient with squamous cell carcinoma of the lung.
Kanai O; Koizumi M; Ito T; Mio T
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38378591
[TBL] [Abstract][Full Text] [Related]
9. Pneumonic-type lung adenocarcinoma with KRAS G12V mutation and sustained response to Afatinib.
Zhao J; Xu J; Qiu T; Wang J; Wang Z
Pneumonia (Nathan); 2024 Apr; 16(1):7. PubMed ID: 38659041
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of erlotinib in NSCLC harboring rare EGFR extracellular domain mutation (T263P) and common mutations: Case report and literature review.
Wang Q; Wang Y; Zhang X; Fang C; Qian X; Li Y
Front Oncol; 2022; 12():954026. PubMed ID: 36212397
[TBL] [Abstract][Full Text] [Related]
11. Limited effect of afatinib in a non-small cell lung cancer patient harboring an epidermal growth factor receptor K860I missense mutation: A case report.
Tamura T; Kawakado K; Makimoto G; Nakanishi M; Kuyama S
Thorac Cancer; 2021 Jun; 12(11):1770-1774. PubMed ID: 33942527
[TBL] [Abstract][Full Text] [Related]
12. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
13. Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature.
Xu H; Liang Q; Xu X; Tan S; Wang S; Liu Y; Liu L
World J Surg Oncol; 2021 Nov; 19(1):330. PubMed ID: 34794435
[TBL] [Abstract][Full Text] [Related]
14. The effect of afatinib and radiotherapy on a patient with lung adenocarcinoma with a rare EGFR extracellular domain M277E mutation and high PD-L1 expression.
Lv D; Wang R; Wang X; Feng H
J Cancer Res Ther; 2022 Apr; 18(2):587-589. PubMed ID: 35645132
[TBL] [Abstract][Full Text] [Related]
15. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of Lung Adenocarcinoma with Epidermal Growth Factor Receptor Compound Mutations Involving Exon 19 Deletion and Exon 20 Insertion by Afatinib.
Ikeuchi T; Tokuyasu H; Ishikawa S
Intern Med; 2019; 58(1):101-104. PubMed ID: 30606938
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
